The overexpression of hypomethylated miR-663 induces chemotherapy resistance in human breast cancer cells by targeting heparin sulfate proteoglycan 2 (HSPG2)

106Citations
Citations of this article
46Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background: miR-663 is related to chemosensitivity in human breast cancer cells. Results: Overexpression of miR-663 was associated with chemoresistance and accompanied by down-regulation of HSPG2. Conclusion: Overexpression of hypomethylated miR-663 induces chemoresistance in breast cancer cells by down-regulating HSPG2. Significance: Learning how miR-663 regulates chemoresistance may provide a potential target for the miRNA-based approach of breast cancer therapy. © 2013 by The American Society for Biochemistry and Molecular Biology, Inc.

Cite

CITATION STYLE

APA

Hu, H., Li, S., Cui, X., Lv, X., Jiao, Y., Yu, F., … Lin, L. (2013). The overexpression of hypomethylated miR-663 induces chemotherapy resistance in human breast cancer cells by targeting heparin sulfate proteoglycan 2 (HSPG2). Journal of Biological Chemistry, 288(16), 10973–10985. https://doi.org/10.1074/jbc.M112.434340

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free